Perspectives of European Patient Advocacy Groups on Volunteer Registries and Vaccine Trials: VACCELERATE Survey Study.
Sophia ThemistocleousChristos D ArgyropoulosParis VogazianosGeorge ShiamakkidesEvgenia NoulaAndria NearchouAndreas YiallourisCharalampos FilippouFiona A StewartMarkela KoniordouIoannis KopsidasHelena H AsklingSirkka VeneAmandine Gagneux-BrunonJana Baranda PrellezoElena AlvarezJon Salmanton-GarcíaJanina LecklerAlan J MackenRuth Joanna DavisAnna Maria AzziniCharis ArmeftisMargot HellemansRomina Di MarzoCatarina LuisOle F OlesenOlena ValdenmaiierStine Finne JakobsenPontus NauclerOdile LaunayPatrick W G MallonJordi OchandoPierre van DammeEvelina TacconelliTheoklis ZaoutisOliver Andreas CornelyZoi Dorothea PanaPublished in: JMIR public health and surveillance (2024)
Factors discouraging participants from joining vaccine trial registries or clinical trials primarily include concerns of the safety of novel vaccines and a lack of trust in those involved in vaccine development. These outcomes aid in identifying issues and setbacks in present registries, providing the VACCELERATE network with feedback on how to potentially increase participation and enrollment in trials across Europe. Development of European health communication strategies among diverse public communities, especially via PAGs, is the key for increasing patients' willingness to participate in clinical studies.
Keyphrases
- clinical trial
- healthcare
- end stage renal disease
- ejection fraction
- mental health
- newly diagnosed
- public health
- chronic kidney disease
- health information
- phase ii
- prognostic factors
- physical activity
- study protocol
- randomized controlled trial
- emergency department
- health insurance
- cross sectional
- patient reported outcomes
- type diabetes
- dna repair
- risk assessment
- skeletal muscle
- climate change
- metabolic syndrome
- patient reported
- human health